Moreover, there were no statistical differences in gender, age, TNM stage, tumor location, or smoking status between PD‐L1‐positive and ‐negative sufferers, or between PD‐L1‐highly positive and ‐weakly positive patients (p > 0.05) (Table 1), indicating the IHC results were comparable. The gene discussed is CD274; the disease is neoplasm.